Serina Therapeutics Inc. (NYSE American: SER) announced the enrollment of the first patient in its Phase 1b registrational trial evaluating ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE